Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.

摘要

Our results provide little support for the previously hypothesized decreased risk of breast cancer with metformin use or for an increased risk with insulin use. Implications for possible residual confounding by screening mammography and comorbidity should be considered in breast cancer pharmacoepidemiology studies.